Jazz Pharmaceuticals plc
JAZZ—
Jazz Pharmaceuticals plcJAZZ$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-5.84
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$4.27B
Net income
$-356.15M
Net margin
-8.3%
Gross margin
14.3%
Dividends & financials
Jazz Pharmaceuticals plc (JAZZ) reported revenue of $4.27B and net income of $-356.15M, or $-5.84 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.